December 13, 2022 10:49 AM EST

MarketingRx roundup: Pfizer teams with NFL player for sickle cell awareness; Astellas crowdsources patient solutions

Beth Snyder Bulik

Senior Editor

Pfizer is driving sickle cell disease awareness on Facebook with ads starring San Francisco 49ers running back Tevin Coleman. Coleman and his wife Akilah Coleman are the parents of five-year-old daughter Nazaneen who lives with sickle cell disease. All three appear in the most recent Facebook ads.

The Coleman family began speaking out about their experiences as part of Global Blood Therapeutics’ “Sickle Cell Speaks” campaign this summer. Pfizer bought GBT, and its sickle cell anemia drug Oxbryta, in a $5.4 billion deal that closed in October.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

MarketingRx roundup: Pfizer teams with NFL player for sickle cell awareness; Astellas crowdsources patient solutions

Beth Snyder Bulik

Senior Editor

Unlock this article instantly by becoming a free subscriber.

FDA rolls out long-awaited proposal to overhaul diagnostics regulation

Despite a summer of blockbuster rounds, biotech funding is on track to level off at pre-pandemic norms

How academic centers are trying to keep their promising drug discoveries out of the ‘valley of death’

FDA unveils new rare disease pilot program to increase agency-sponsor communications

In the race to get type 1 patients off insulin, focus turns to cell transplants and insulin-producing stem cells

Data Quality 2.0: The Future of Real-World Evidence

Mar­ket­ingRx roundup: Pfiz­er teams with NFL play­er for sick­le cell aware­ness; Astel­las crowd­sources pa­tient so­lu­tions

Beth Snyder Bulik

Senior Editor

Unlock this article instantly by becoming a free subscriber.

FDA rolls out long-await­ed pro­pos­al to over­haul di­ag­nos­tics reg­u­la­tion

De­spite a sum­mer of block­buster rounds, biotech fund­ing is on track to lev­el off at pre-pan­dem­ic norms

How aca­d­e­m­ic cen­ters are try­ing to keep their promis­ing drug dis­cov­er­ies out of the ‘val­ley of death’

FDA un­veils new rare dis­ease pi­lot pro­gram to in­crease agency-spon­sor com­mu­ni­ca­tions

In the race to get type 1 pa­tients off in­sulin, fo­cus turns to cell trans­plants and in­sulin-pro­duc­ing stem cells

Da­ta Qual­i­ty 2.0: The Fu­ture of Re­al-World Ev­i­dence

MarketingRx roundup: Pfizer teams with NFL player for sickle cell awareness; Astellas crowdsources patient solutions

FDA rolls out long-awaited proposal to overhaul diagnostics regulation

Despite a summer of blockbuster rounds, biotech funding is on track to level off at pre-pandemic norms

How academic centers are trying to keep their promising drug discoveries out of the ‘valley of death’

FDA unveils new rare disease pilot program to increase agency-sponsor communications

In the race to get type 1 patients off insulin, focus turns to cell transplants and insulin-producing stem cells

Data Quality 2.0: The Future of Real-World Evidence